Celyad Oncology SA
EBR:CYAD.BR
0.5 (EUR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 7.004 | 12.445 | 30.018 | 17.234 | 39.338 | 40.542 | 23.253 | 48.357 | 100.175 | 27.633 | 19.058 | 1.645 | 0 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 9.197 | 10.653 | 34.23 | 7.338 | 2.671 | 3 | 0 | 0 |
Cash and Short Term Investments
| 7.004 | 12.445 | 30.018 | 17.234 | 39.338 | 49.739 | 33.906 | 82.587 | 107.513 | 30.304 | 22.058 | 1.645 | 0 |
Net Receivables
| 0.38 | 1.259 | 2.34 | 0.907 | 2.702 | 0.277 | 0.081 | 0.054 | 0.062 | 1.717 | 0.149 | 0.443 | 1.013 |
Inventory
| -0.077 | 0 | 0 | 1.563 | 0 | 0 | 0 | 0.642 | 0.199 | 0.913 | 0 | -1.645 | 0 |
Other Current Assets
| 3.814 | 1.121 | 1.934 | 2.076 | 0.796 | 1.676 | 2.559 | 2.726 | 0.544 | 2.6 | 0.123 | 0.249 | 1.802 |
Total Current Assets
| 11.121 | 14.825 | 34.292 | 19.705 | 42.836 | 51.692 | 36.394 | 85.367 | 109.419 | 32.935 | 22.602 | 2.192 | 3.469 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 1.83 | 0.309 | 3.248 | 4.119 | 5.061 | 3.014 | 3.29 | 3.563 | 1.136 | 0.598 | 0.243 | 0.383 | 0.355 |
Goodwill
| 0.342 | 0 | 0.883 | 0.883 | 0.883 | 0.883 | 0.914 | 1.04 | 1.003 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.048 | 0.864 | 35.285 | 35.288 | 35.316 | 35.281 | 35.594 | 48.526 | 47.786 | 10.266 | 9.4 | 0 | 0 |
Goodwill and Intangible Assets
| 0.39 | 0.864 | 36.168 | 36.171 | 36.199 | 36.164 | 36.508 | 49.566 | 48.789 | 10.266 | 9.4 | 11.02 | 2.87 |
Long Term Investments
| 0 | 0 | 2.209 | 5.796 | 5.483 | 3.214 | 0.273 | 0.311 | 0.181 | 0.068 | 0 | 0.151 | 0 |
Tax Assets
| 0 | 0 | -2.209 | -5.796 | -5.483 | -3.214 | -0.273 | -0.311 | -0.181 | 0 | 0 | -0.151 | 0 |
Other Non-Current Assets
| 2.941 | 3.718 | 6.235 | 6.089 | 5.74 | 3.429 | 1.434 | 0.311 | 0.18 | 0.109 | 0.14 | 0.151 | 0.183 |
Total Non-Current Assets
| 5.161 | 4.891 | 45.651 | 46.379 | 47 | 42.607 | 41.232 | 53.44 | 50.105 | 11.041 | 9.783 | 11.554 | 3.408 |
Total Assets
| 16.282 | 19.716 | 79.943 | 66.084 | 89.836 | 94.299 | 77.626 | 138.805 | 159.525 | 43.976 | 32.386 | 13.746 | 6.877 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 1.243 | 4.752 | 6.611 | 4.736 | 6.969 | 5.916 | 4.8 | 8.098 | 8.576 | 4.042 | 2.169 | 1.77 | 1.086 |
Short Term Debt
| 0.156 | 0.137 | 0.902 | 1.113 | 1.359 | 0.765 | 0.636 | 0.561 | 0.248 | 0.134 | 0.079 | 0.408 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 1.351 | 0.947 | 0 | 0 | 0 | 0.103 | 0.056 | 0.061 |
Deferred Revenue
| 0 | 1.326 | 1.458 | 2.209 | 0.346 | 0.276 | 0.226 | 1.108 | 0.898 | 0.777 | 0.428 | 0.645 | 0 |
Other Current Liabilities
| 1.533 | 5.537 | 6.314 | 5.985 | 3.594 | 1.339 | 1.336 | 1.508 | 2.666 | 1.877 | 0.609 | 0.598 | 4.774 |
Total Current Liabilities
| 2.932 | 10.426 | 13.827 | 11.834 | 11.922 | 9.647 | 7.945 | 11.275 | 11.49 | 6.053 | 3.389 | 2.731 | 5.921 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 0.902 | 0.118 | -13.002 | -13.615 | 3.004 | 0.881 | 0.808 | 0.917 | 0.427 | 0.279 | 0.027 | 0.921 | 0.116 |
Deferred Revenue Non-Current
| 0 | 4.584 | 5.851 | 4.22 | 4.139 | 2.864 | 1.544 | 7.33 | 10.484 | 10.778 | 12.072 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 14.732 | 16.14 | 0 | 3.212 | 0.204 | 0.204 | 0.121 | 0 | -12.072 | 0 | 0 |
Other Non-Current Liabilities
| 6.144 | 0.271 | 0.164 | 0.371 | 25.152 | 22.106 | 21.134 | 35.525 | 36.014 | 10.96 | 12.072 | 21.751 | 0 |
Total Non-Current Liabilities
| 7.046 | 4.973 | 22.477 | 23.256 | 32.295 | 29.063 | 22.146 | 36.646 | 36.562 | 11.239 | 12.099 | 12.328 | 0.116 |
Total Liabilities
| 9.978 | 15.399 | 36.304 | 35.09 | 44.217 | 38.71 | 30.091 | 47.921 | 48.052 | 17.292 | 15.488 | 15.058 | 6.037 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 32.949 | 78.585 | 78.585 | 48.513 | 48.513 | 41.553 | 34.337 | 32.571 | 32.571 | 24.615 | 22.138 | 9.975 | 9.975 |
Retained Earnings
| -358.372 | -349.947 | -308.997 | -91.826 | -74.424 | -217.778 | -180.421 | -124.026 | -100.313 | -71.215 | -36.388 | -11.287 | -9.134 |
Accumulated Other Comprehensive Income/Loss
| 331.727 | 269.362 | 267.734 | 30.958 | 28.181 | 25.667 | 23.322 | 24.329 | 21.205 | 19.982 | -1.872 | 0 | 0 |
Other Total Stockholders Equity
| 0 | 6.317 | 6.317 | -147.864 | 43.349 | 206.149 | 170.297 | 158.01 | 158.01 | 53.302 | 30.474 | -1.954 | -0 |
Total Shareholders Equity
| 6.304 | 4.317 | 43.639 | 30.994 | 45.619 | 55.591 | 47.535 | 90.884 | 111.473 | 26.684 | 16.898 | -1.312 | 0.84 |
Total Equity
| 6.304 | 4.317 | 43.639 | 30.994 | 45.619 | 55.591 | 47.535 | 90.884 | 111.473 | 26.684 | 16.898 | -1.312 | 0.84 |
Total Liabilities & Shareholders Equity
| 16.282 | 19.716 | 79.943 | 66.084 | 89.836 | 94.301 | 77.626 | 138.805 | 159.525 | 43.976 | 32.386 | 13.746 | 6.877 |